Skip to content

RADX RADIOPHARM THERANOSTICS LTD

Follow

SPONSORED ADS (ADR), issuer CIK 1949257

6 managers (6 13F filers) reported a position in RADX shares at 2026-06-30, 51,124,028 shares in all. 0 filers opened a position and 1 filer sold out during the quarter.

Managers
6
13F filers
6
New
0
Added
3
Reduced
1
Sold out
1
Shares held by filers
51,124,028

Shares held by filers adds up every 13F filer's report, so a share reported by a parent and by its subsidiary counts twice (H9). Managers counts each filer group once.

13D and 13G filers

Each filer's latest stake. The shares are the aggregate the reporting persons state, which can include entities that file no 13F.

Insider trades

No Form 4 transaction on this security in the data.

13F holders, Q2 2026

Filers in the available 13F reports with a share position at 2026-06-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.

HolderSharesValue% of portfolioChangeSource
Stonepine Capital Management, LLCin group Stonepine Capital Management,…51,000,000$670K0.51%013F-HR/ATimelineGroup
HSBC HOLDINGS PLCin group HSBC HOLDINGS PLC62,188$254K<0.01%+81613F-HRTimelineGroup
Regal Partners Ltdin group Regal Partners Ltd40,138$168K0.01%013F-HRTimelineGroup
PNC Financial Services Group, Inc.in group PNC Financial Services Group,…20,000$83.8K<0.01%+4,00013F-HRTimelineGroup
UBS Group AGin group UBS Group AG1,507$6.31K<0.01%-1,49313F-HRTimelineGroup
RHUMBLINE ADVISERS195$817<0.01%+7413F-HRTimeline

Events

  • MORGAN STANLEY and 1 other reporting person reported 272,558,527 RADX shares, 5.6% of the class, as of 2026-09-30, in a 13G filed 2026-11-13. 0000895421-26-000333

    Accepted , ingested
  • Regal Partners Funds Management Pty Ltd and 1 other reporting person reported 157,139,443 RADX shares, 3.34% of the class, as of 2026-09-30, in a 13G filed 2026-10-14. 0001214659-26-012928

    Accepted , ingested